New dual-target drug may help overcome immunotherapy resistance in pancreatic cancer
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
New dual-target drug may help overcome immunotherapy resistance in pancreatic cancer
Revealing the unusual ability of a protein involved in lung and thyroid cancer
Age, sex, and cancer type influence risk of subsequent cancers among survivors
New research challenges understanding of mRNA vaccines and establishes innovative way to make them more effective
Brain structure differences may explain striking ancestry gaps in blood cancers
How cells decide when to react could shape future treatments for cancer and fibrosis
Mail-in test for colorectal cancer could help community health centers increase screening
As heart, kidney and metabolic health worsen, cancer risk may rise
Researchers identify promising new therapeutic target for pancreatic cancer
Targeted therapy drug shows early promise against KRAS-driven lung and pancreatic cancers
New molecular tool transforms how clinicians classify and treat a rare blood cancer
An unprecedented view of the immune system’s killer cells